Supreme Court: General Fraud Allegations Cannot Extend Limitation under Section 74 CGST Act  ||  SC: ‘No Coercive Steps’ Order Cannot Restrain Filing of Charge Sheet  ||  Chhattisgarh HC: Maintenance for Autistic Child May Continue Beyond 18 Until Self-Sufficient  ||  P&H HC: 45-Day Delay in Informing Detenue of Representation Right Violates Article 22(5)  ||  Rajasthan HC Bars Courts from Protecting those Responsible for Building Defects at their Own Peril  ||  Allahabad HC: Clarification Issued Before Decision Applies to Pending Tender Complaints  ||  Allahabad HC: Father’s Custody Cannot be Denied without Proof of Guardianship Unfitness  ||  Bombay High Court: Each Petitioner Must Pay Court Fee Where Causes of Action are Separate  ||  P&H High Court: Counsel’s Ignorance of Readily Available Prior Litigation Amounts to Dereliction  ||  SC: Amendments to Government Orders Must Be Construed Fairly to Prevent Hardship    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved